Karyopharm Therapeutics Inc
General ticker "KPTI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $95.0M
Karyopharm Therapeutics Inc does not follow the US Stock Market performance with the rate: -18.1%.
Estimated limits based on current volatility of 3.7%: low 0.62$, high 0.66$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.64$, 2.21$]
- 2024-12-30 to 2025-12-30 estimated range: [1.10$, 3.29$]
Financial Metrics affecting the KPTI estimates:
- Negative: Non-GAAP EPS, $ of -1.25 <= 0.10
- Negative: Operating profit margin, % of -47.01 <= 1.03
- Negative: Operating cash flow per share per price, % of -50.75 <= 2.35
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Interest expense per share, $ of 0.21 <= 0.74
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
Short-term KPTI quotes
Long-term KPTI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $209.82MM | $157.07MM | $146.03MM |
| Operating Expenses | $308.09MM | $299.28MM | $275.57MM |
| Operating Income | $-98.27MM | $-142.20MM | $-129.54MM |
| Non-Operating Income | $-25.55MM | $-22.72MM | $-13.24MM |
| Interest Expense | $26.05MM | $25.00MM | $23.82MM |
| R&D Expense | $160.84MM | $148.66MM | $138.75MM |
| Income(Loss) | $-123.82MM | $-164.92MM | $-142.78MM |
| Taxes | $0.27MM | $0.37MM | $0.32MM |
| Profit(Loss) | $-124.09MM | $-165.29MM | $-143.10MM |
| Stockholders Equity | $-79.67MM | $-16.66MM | $-136.21MM |
| Inventory | $4.11MM | $4.22MM | $3.04MM |
| Assets | $305.31MM | $358.17MM | $240.44MM |
| Operating Cash Flow | $-107.12MM | $-149.55MM | $-92.72MM |
| Capital expenditure | $5.71MM | $0.12MM | $0.00MM |
| Investing Cash Flow | $141.84MM | $-104.26MM | $7.94MM |
| Financing Cash Flow | $73.65MM | $193.74MM | $1.12MM |
| Earnings Per Share* | $-1.65 | $-2.02 | $-1.25 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.